Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Not yet recruiting	Phase 1 / Phase 2	2026-01-27		NCT07370064

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Xuzhou Medical University	17
Yake Biotechnology Ltd.	30

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Affiliated Hospital oh Xuzhou Medical University	Xuzhou	China	2

Clinical trials